Headline News about Biontech Se ADR
BioNTech Starts Dosing In Herpes Vaccine Candidate Study
December 21, 2022
Via Benzinga
Will Investors Notice Exciting Sign On BioNTech's Chart?
December 19, 2022
Via Benzinga
BioNTech, Ryvu Therapeutics Join Forces For Immuno-Modulatory Candidates
November 30, 2022
Via Benzinga
BioNTech Stock Gets Upgrade, Analyst Sees Multiple Upside Opportunities
December 15, 2022
Via Benzinga
FDA Authorizes Pfizer/BioNTech And Moderna's Bivalent COVID Shots For 6 Months Old
December 08, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
Via Benzinga
Via Benzinga
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|